Harvard Bioscience (HBIO) Appoints McNaughton New CFO

November 17, 2008 7:52 AM EST

Harvard Bioscience, Inc. (Nasdaq: HBIO) announced the hiring and appointment of Thomas McNaughton as its new Chief Financial Officer effective immediately.

Mr. McNaughton most recently served as Chief Financial Officer for Tivoli Audio, LLC a venture capital-backed global manufacturer of premium audio systems. Prior to joining Tivoli, Mr. McNaughton spent 14 years at Cabot Corporation (NYSE: CBT) where he most recently held the position of Chief Financial Officer of Cabot Supermetals, a $350 million Cabot Corporation division that provides high purity tantalum and niobium products to the electronics and semiconductor industries.

Harvard Bioscience ("HBIO") is a global developer, manufacturer, and marketer of a broad range of specialized products, primarily scientific instruments and apparatus, used to advance life science research at pharmaceutical and biotechnology companies, universities and government laboratories worldwide.
Sign up at EasyStockAlerts.com To Be Alerted To Your Stock News Today!


Related Categories

Management Changes

Stocks Mentioned

CBT 22.88

+1.03 +4.71%
Volume: 340,524
Track CBT

HBIO 3.92

+0.05 +1.29%
Volume: 70,692
Track HBIO


Add Your Comment